2. Background
Incidence
○ 20% at 28 weeks
○ 4% at term
Reasons for a breech
○ Uterine abnormalities
○ Placental localisation
○ Excessive or reduced amniotic fluid
○ Fetal abnormalities
○ Fetal attitude – extended legs
○ Just chance
3. Perinatal mortality is increased
because…
Prematurity
Congenital malformations
Birth asphyxia
Birth trauma
“the biggest part of the baby is coming
last”
Increased risk of long term “handicap”
even when delivered by CS
4. Current Controversies
Management of term breech
Elective Caesarean or vaginal birth
Selection of patients for breech birth
Techniques in vaginal breech delivery
Pre term breech and the twin breech
The detection of breech presentation
The Role of ECV
Is it effective
Is it safe
When should it be performed
How is it best achieved
5. Recent History
By 1990
The practice of ECV had been mostly abandoned
Because of reports of intrauterine death
But it was done at 33 – 35 weeks
And therefore possibly unnecessary
Most Pre term breech delivered by CS
Because of concerns about incomplete cervical
dilatation
But there was no good evidence to support this
Confusion about the Primigravid Breech
With the “untried pelvis”
Breech skills were being lost
6. 2000 The Term Breech Trial
RCT in 121 centres in 26 countries & 2088 women
To prove that vaginal breech was safe & to maintain
breech skills
Multiparous or nulliparous at term with a singleton
breech
Non-footling, EFW <4000g & morphologically
normal
Randomised to elective CS or trial of vaginal
delivery
Induction & augmentation of labour permitted
Experienced accoucheur to be present
But this trial was stopped prematurely because
increased perinatal risk with vaginal breech delivery
7. Risks to the baby & the mode of
delivery…
After exclusion of deaths from congenital
malformation the risk of perinatal death or
serious morbidity is reduced by elective CS (RR
0.29, CI 0.10 – 0.86)
After excluding cases with:
○ Epidural anaesthesia
○ Prolonged labour
○ Labours induced or augmented
○ Footling breech
○ No experienced accoucheur present
Risk with vaginal birth still 3.3% but 1.3% with
elective CS (RR 0.49, CI 0.26 – 0.91)
This data from systematic analysis of the
Term Breech Trial plus two smaller prior trials
8. Risks to the mother & mode of
delivery…
Short term morbidity is increased by
vaginal delivery (RR 1.29 CI 1.03 – 1.61)
Urinary incontinence
More perineal pain
Long term morbidity from uterine scar
needs evaluation
Estimated that for each baby saved by CS there will
be one scar rupture in attempted VBAC later
In the Netherlands, in the 4 years after 2000, 8500
CS were done, “saved” 19 babies but 4 maternal
deaths occurred
Needs 53 additional CS for each baby saved
9. Events since the publication of the Term
Breech Trial…
Many criticisms of the Trial
Follow up of the Term Breech Trial babies
found no long term benefit from CS
A prospective study of 2526 women in
France and Belgium analyzed on an
intention-to-treat basis found no benefit
from elective CS
RCOG, RANZCOG and Canadian
guidelines state that trial of vaginal
breech delivery is a safe option
All also recommend attempting ECV
10. Other Major Studies
A prospective study of 2526 women in
France and Belgium analyzed on an
intention-to-treat basis found no benefit
from elective CS
Dutch study of 58,320 term breech 1999-
2007
Elective CS rose from 24% to 60%
PNM fell from 1.3 to 0.7 per 1000
PNM for those having vaginal birth did not
change
11. Problems with the Term Breech Trial…
Most of the patients recruited in developed
countries
Subgroup analysis suggests that the outcome cannot
be extrapolated to resource poor countries
Many of the centres involved had historically low
rates of vaginal breech birth
Raises questions about the experience of the “skilled
accoucheur”
Criteria for patients for trial of vaginal birth were
too liberal
Lumping fetal mortality and morbidity was
inappropriate for long term outcomes
3 deaths in the vaginal group vs none in the CS group
is NS (and one death was a surviving twin)
12. Two year follow up of babies in the
Term Breech Trial…
Was conducted in those Centres thought to achieve
80% follow up
Outcomes measured were perinatal death and
neurodevelopmental delay
There were no significant differences (RR 1.09 CI
0.52 – 2.30)
The smaller number of perinatal deaths in the CS
group was balanced by a higher number of 2 year-
olds with neuro-developmental delay
Calls into question the measures of neonatal
morbidity (which were more frequent in the vaginal
birth group)
13. Patients not suitable for vaginal breech
birth…
Other obstetric contraindications incl. placenta
previa, compromised fetus and previous CS
Footling or kneeling breech
EFW >3800 or <2000g
Hyper extended neck – ultrasound or X-ray
Routine radiological pelvimetry not required but
patients with a small pelvis not suitable
But maybe a role for CT pelvimetry
Experienced accoucheur not available
Diagnosis of the breech in labour is not a
contraindication
14. Optimal intrapartum management…
Induction of labour is okay
But augmentation of labour not recommended
Epidural according to the mother’s wishes
Continuous CTG is recommended
CS should be performed for failure to progress on
the 1st stage and failure of the breech to descend
in the second stage
40 – 50% of patients attempting vaginal birth will
require Caesarean
And, because both baby and maternal outcomes
are worse with emergency CS, this is why I prefer
elective CS
15. The breech delivery…
Episiotomy when clinically indicated
Routine breech extraction not recommended
(But delivery should not be unduly delayed)
Delivery of the arms
Sweep them down or…
Lovset’s maneuvre
Delayed engagement of the head
Suprapubic pressure or…
Mauriceau-Smellie-Veit with or without rotation
Delivery of the head
Burns-Marshall or…
Mauriceau-Smellie-Veit
Symphysiotomy and forceps for trapped head
16. Pre term Breech
Retrospective studies suggest that delivery
by CS confers advantage to the baby
Especially for the very pre term
But the data is biased
And maternal risk needs to be taken into
account
So the best option is to make individual
decisions
With the involvement of the patient
Incomplete dilation is a problem
Cervical incisions recommended
17. Twins and Breech
Many clinicians recommend CS when the
leading twin is breech
But data is lacking to confirm this trend
And locked twins are very rare
Routine CS for a second twin that is
breech is not recommended
But is sometimes required
Some RCT’s have been performed and CS
not shown to confer any benefit
More studies are underway
Breech extraction of the second twin is an
option
18. Detection of breech presentation…
Antenatal diagnosis is inconsequential before 35
weeks
But detection in labour is too late because…
Maternal counseling is compromised
Place of labour may be inappropriate
Risks to mother and baby both increased regardless of the
mode of delivery
In a study of 1633 women attending the
antenatal clinic of a tertiary Sydney hospital
30% of breech presentations were missed
Conclusion:
Ultrasound for presentation at 36 – 37 weeks
should be a component of routine antenatal care
19. Because breech delivery is a
preventable condition that meets all
the criteria for a screening procedure
The Role of External Cephalic
Version
20. ECV is Effective
RCT’s of external version at or near term (5
trials and 433 women)
Reduce the rate of breech presentation in
labour (RR 0.38, CI 0.18 – 0.80)
Reduce the rate of CS (RR 0.55, CI 0.33 –
0.91)
Overall success rate is:
60% in multipara
40% in primipara
Lower when the legs are extended
Or the breech is deeply engaged
21. Risks with ECV
Cord entanglement
Post procedure monitoring by CTG
Transient decelerations common with a known nuchal
cord
Premature labour and PROM
Not a problem if it is deferred until >37w
Antepartum haemorrhage
Anti-D for those patients who are Rh Neg
Maternal pain
Limits continuation with the attempt in ~ 5%
Fetal reversion to breech
Overall less than 5% and is usually predictable
22. ECV is Safe
No differences in any measure of baby or
maternal outcome in the RCT’s
Has a low rate of complications in large
observational studies
O.5% rate of emergency CS in 805
consecutive cases in Oxford
One Term PROM in a personal series of >200
attempted ECV’s over 15 years
No documented case of procedure-related
perinatal loss in the large trials
And few in the literature overall
23. An attempt at ECV is not
contraindicated by…
Advanced gestation
A uterine scar
History of prior APH
Maternal hypertension
Oligohydramnios
A nuchal cord
And is usually limited only by the maternal willingness
to consider and continue the procedure
Which in turn is usually proportional to the counseling
that is initially and subsequently provided
24. ECV is not successively achieved by…
Maternal posturing
5 trials 392 women
Moxibustion with or without acupuncture
3 trials 597 women
The need for ECV was reduced in one study
But ECV is facilitated by…
Tocolysis with IV or SC betamimetic agents
Betamimetics better than oral Nifedipine &
sublingual nitroglycerine is not recommended
Epidural but not spinal anaesthesia
Fetal acoustic stimulation
25. Unanswered Questions about
ECV
When it should be attempted
Beginning earlier at 34 – 36w may be okay
Should attempts be repeated
How many times
How often
Role in the fetus who has an unstable lie
Role with amnioreduction and
amnioinfusion
Teaching and maintaining skills
26. The Early ECV Trial
1543 ♀ in 21 countries randomised to:
ECV at 34 – 36 weeks or
>37 weeks
Fewer breeches at term from early ECV
RR 0.84 CI 0.75 – 0.94 (41% vs 48%)
But rate of Caesarean not reduced
Inexplicable
Early ECV appears safe
No difference in fetal/neonatal morbidity
But a meta analysis suggests increased risk
of preterm labour
Discuss benefits and risks and choose